Literature DB >> 15876480

BRCA1-2 mutations in breast cancer: identification of nine new variants of BRCA1-2 genes in a population from central Western Spain.

Raquel Salazar1, Juan Jesús Cruz-Hernandez, Enrique Sanchez-Valdivieso, César A Rodriguez, Amalia Gomez-Bernal, Elviradel Barco, Emilio Fonseca, Teresa Portugal, Rogelio Gonzalez-Sarmiento.   

Abstract

We carried out a mutational analysis of BRCA1 and BRCA2 genes in 103 individuals from a population in Western Central Spain and we identified nine new variants: two truncating mutations in BRCA2 [2604C>A (Y792X), 8873del4], three missense mutations in BRCA2 [677A>G (H150R), 958G>A (D224N) and 3398A>G (K1057R], and four silent mutations, two in BRCA1 [1115T>G (R332R) and IVS24+36 C>G], and two in BRCA2 [2583T>A (I785I) and 7854G>A (T2542T)]. In two unrelated families of our population, we identified the BRCA1 1806C>T (Q563X) mutation, which is considered to be a Swedish founder mutation. BRCA1 1806C>T (Q563X) and BRCA2 3036del4 gene mutations were the most frequent in our series.

Entities:  

Mesh:

Year:  2006        PMID: 15876480     DOI: 10.1016/j.canlet.2005.03.006

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  High proportion of novel mutations of BRCA1 and BRCA2 in breast/ovarian cancer patients from Castilla-León (central Spain).

Authors:  Mar Infante; Mercedes Durán; Eva Esteban-Cardeñosa; Cristina Miner; Eladio Velasco
Journal:  J Hum Genet       Date:  2006-06-07       Impact factor: 3.172

2.  Heterogeneous prevalence of recurrent BRCA1 and BRCA2 mutations in Spain according to the geographical area: implications for genetic testing.

Authors:  Orland Diez; Sara Gutiérrez-Enríquez; Judith Balmaña
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

3.  Low prevalence of BRCA1 and BRCA2 mutations in the sporadic breast cancer of Spanish population.

Authors:  Inmaculada de Juan Jiménez; Eva Esteban Cardeñosa; Sarai Palanca Suela; Eva Barragán González; Ismael Aznar Carretero; Blanca Munárriz Gandía; Ana Santaballa Bertran; María Dolores Torregrosa Maicas; Carmen Guillén Ponce; Ana Beatriz Sánchez Heras; Ana Bayón Lara; Oscar Fuster Lluch; Pascual Bolufer Gilabert
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

4.  Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.

Authors:  Xavier Gabaldó Barrios; Mª Desamparados Sarabia Meseguer; Miguel Marín Vera; Ana Isabel Sánchez Bermúdez; José Antonio Macías Cerrolaza; Pilar Sánchez Henarejos; Marta Zafra Poves; Mª Rosario García Hernández; Encarna Cuevas Tortosa; Ángeles Aliaga Baño; Verónica Castillo Guardiola; Pedro Martínez Hernández; Isabel Tovar Zapata; Enrique Martínez Barba; Francisco Ayala de la Peña; José Luis Alonso Romero; José Antonio Noguera Velasco; Francisco Ruiz Espejo
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

5.  Novel germline mutations in BRCA2 gene among 96 hereditary breast and breast-ovarian cancer families from Kerala, South India.

Authors:  Vani Syamala; Leelakumari Sreeja; Volga S Syamala; B Vinodkumar; Praveenkumar B Raveendran; Hariharan Sreedharan; Ratheesan Kuttappan; Lekshmi Balakrishnan; Ravindran Ankathil
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-15       Impact factor: 4.553

6.  Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome.

Authors:  Ingrid P Ewald; Patrícia Izetti; Fernando R Vargas; Miguel Am Moreira; Aline S Moreira; Carlos A Moreira-Filho; Danielle R Cunha; Sara Hamaguchi; Suzi A Camey; Aishameriane Schmidt; Maira Caleffi; Patrícia Koehler-Santos; Roberto Giugliani; Patricia Ashton-Prolla
Journal:  Hered Cancer Clin Pract       Date:  2011-12-20       Impact factor: 2.857

7.  Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.

Authors:  Felipe Vaca-Paniagua; Rosa María Alvarez-Gomez; Verónica Fragoso-Ontiveros; Silvia Vidal-Millan; Luis Alonso Herrera; David Cantú; Enrique Bargallo-Rocha; Alejandro Mohar; César López-Camarillo; Carlos Pérez-Plasencia
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

8.  Prevalence and impact of founder mutations in hereditary breast cancer in Latin America.

Authors:  Patricia Ashton-Prolla; Fernando Regla Vargas
Journal:  Genet Mol Biol       Date:  2014-03       Impact factor: 1.771

9.  Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.

Authors:  Giulia Cini; Massimo Mezzavilla; Lara Della Puppa; Elisa Cupelli; Alessio Fornasin; Angela Valentina D'Elia; Riccardo Dolcetti; Giuseppe Damante; Sara Bertok; Gianmaria Miolo; Roberta Maestro; Paolo de Paoli; Antonio Amoroso; Alessandra Viel
Journal:  BMC Med Genet       Date:  2016-02-06       Impact factor: 2.103

10.  Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain).

Authors:  Pilar Blay; Iñigo Santamaría; Ana S Pitiot; María Luque; Marta G Alvarado; Ana Lastra; Yolanda Fernández; Angeles Paredes; José M P Freije; Milagros Balbín
Journal:  BMC Cancer       Date:  2013-05-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.